Sandbox:Hannan: Difference between revisions
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
|- | |- | ||
|'''Wingless and integration-1 (Wnt) signaling''' | |'''Wingless and integration-1 (Wnt) signaling''' | ||
* '''Canonical pathway''' | |||
'''Activation of Wnt pathway → binding of Wnt ligands to Wnt co-receptors LRP5/6 and one trans-membrane receptor of the FDZ family →''' | '''Activation of Wnt pathway → binding of Wnt ligands to Wnt co-receptors LRP5/6 and one trans-membrane receptor of the FDZ family →''' | ||
Line 10: | Line 11: | ||
'''activation of T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors → ↑ bone formation and ↓ bone resorption''' | '''activation of T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors → ↑ bone formation and ↓ bone resorption''' | ||
* Binding of PTH to PTH1 receptor may result in activation of | * '''Non-canonical WNT–planar cell polarity (WNT–PCP) pathway''' | ||
'''Formation of WNT ligand–receptor tyrosine kinase-like orphan receptor 2 (ROR2) or the receptor-like tyrosine kinase (RYK)–FZD–DVL complex''' | |||
'''→ activation of one of these 3 pathways: 1) Disheveled-associated activator of morphogenesis 1 (DAAM1)–RHO–RHO-associated kinase (ROCK) pathway; 2) RAC–Jun kinase (JNK)–RUNX2 pathway; WNT–Ca<sup>2+</sup> pathway''' | |||
* Binding of PTH to PTH1 receptor may result in activation of Wnt pathway | |||
* This pathway is also involved in cell-cycle promotion and cell growth | * This pathway is also involved in cell-cycle promotion and cell growth | ||
* | * |
Revision as of 19:37, 29 October 2018
Molecular pathways and factors associated with osteoblastic activity | Association with multiple myeloma |
---|---|
Wingless and integration-1 (Wnt) signaling
Activation of Wnt pathway → binding of Wnt ligands to Wnt co-receptors LRP5/6 and one trans-membrane receptor of the FDZ family → formation of DVL–Axin–FRAT1–GSK-3β complex → translocation of β-catenin from cytoplasm to nucleus → activation of T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors → ↑ bone formation and ↓ bone resorption
Formation of WNT ligand–receptor tyrosine kinase-like orphan receptor 2 (ROR2) or the receptor-like tyrosine kinase (RYK)–FZD–DVL complex → activation of one of these 3 pathways: 1) Disheveled-associated activator of morphogenesis 1 (DAAM1)–RHO–RHO-associated kinase (ROCK) pathway; 2) RAC–Jun kinase (JNK)–RUNX2 pathway; WNT–Ca2+ pathway
|
Dickkopf 1 (Dkk-1)
Sclerostin
Secreted frizzled related protein-2 (sFRP-2)
Periostin
|
Transforming Growth Factor-β
|